Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 8, 2019
[ Wed, May 08th 2019
] - WOPRAI
[ Wed, May 08th 2019
] - WOPRAI
Tue, May 7, 2019
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
[ Tue, May 07th 2019
] - WOPRAI
Mon, May 6, 2019
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
[ Mon, May 06th 2019
] - WOPRAI
Paul Choi Initiated (BHVN) at Strong Buy and Held Target at $92 on, May 6th, 2019
Paul Choi of Goldman Sachs, Initiated "Biohaven Ltd." (BHVN) at Strong Buy and Held Target at $92 on, May 6th, 2019.
Paul has made no other calls on BHVN in the last 4 months.
There are 4 other peers that have a rating on BHVN. Out of the 4 peers that are also analyzing BHVN, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold on, Tuesday, April 9th, 2019
These are the ratings of the 3 analyists that currently disagree with Paul
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $67 on, Tuesday, April 23rd, 2019
- Esther Rajavelu of "Oppenheimer" Maintained at Buy with Increased Target to $70 on, Monday, April 15th, 2019
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $89 on, Monday, April 15th, 2019
